The American Medical Association (AMA), Omada Health, and Intermountain Healthcare today announced an innovative initiative aimed at reducing the alarming number of adults who develop type 2 diabetes. The new collaboration will create a roadmap for large health care organizations across the country to adopt proven online behavior change interventions for at-risk patients, and integrate those programs into provider referral and clinical workflow.
"We're delighted to be partnering with the country's premier physician organization and one of the most innovative health systems in the United States," said Omada Health CEO Sean Duffy. "Intermountain's integration of the Omada program, and AMA's focus on ensuring digital tools work to empower providers will give patients with prediabetes another proven option to meet their care needs. It will also give physicians and their care teams additional treatment options, and actionable data to better understand how to deliver lasting lifestyle change for those in need of it."
Read More: http://ivpost.com/index.php/8-health/1654-ama-omada-health-intermountain-healthcare-partner-to-reduce-incidence-of-type-2-diabetes
AMA, Omada Health, Intermountain Healthcare Partner to Reduce Incidence of Type 2 Diabetes7/30/2016
Via: IV Post Via: Interbrand NEW YORK, New York (26 July 2016) – Today, Interbrand launches the inaugural Interbrand Breakthrough Brands report, in partnership with Facebook, Ready Set Rocket, and the New York Stock Exchange (NYSE). The Interbrand Breakthrough Brands report, entitled “Future Growth,” is unique in that it examines emerging companies that are brand-led—organizations that have both unique business models and strong brands. The report complements Interbrand’s annual Best Global Brands report, now entering its 17th year, by putting a spotlight on emerging brands—especially those that are affecting change and embodying growth. Via: Omada Health Blog By: Sean Duffy, Omada Health CEO Martin Emerson has joined Monteris Medical Inc. as CEO about two months after his previous business, Galil Medical Inc., was sold in a deal worth up to $110 million. Via: CNN "...In California and Washington state, San Francisco-based Omada Health is testing a version of Prevent, a diabetes and heart disease prevention program that's been modified for "underserved" populations -- basically people on Medicaid or who are uninsured. The free program offers patients a digital scale as well as behavior counseling and education, access to a personal health coach and an online peer network. |
Archives
October 2023
|